A patient with a history of asthma presents with increased shortness of breath, fatigue, chest tightness, and a respiratory rate of 28 breaths per minute. Her oxygen saturation is 88% on room air, and auscultation reveals diffuse wheezing and diminished breath sounds. Which of the following is the most appropriate initial nursing intervention to address her current respiratory status?

C) Initiate supplemental oxygen to maintain saturation above 92%.

A) Administer a nebulized bronchodilator treatment.

B) Encourage the patient to perform pursed-lip breathing exercises.

C) Initiate supplemental oxygen to maintain saturation above 92%.

D) Position the patient in a high Fowler's position to ease breathing.

A patient with a history of asthma is experiencing an acute exacerbation characterized by increased shortness of breath, fatigue, and a persistent tight feeling in the chest. Despite frequent use of her Albuterol inhaler, her symptoms persist. Her respiratory rate is 28 breaths per minute, and oxygen saturation is 88% on room air. Which nursing intervention is the priority in managing this patient's current condition?

B) Provide supplemental oxygen to maintain oxygen saturation above 92%.

A) Administer a dose of systemic corticosteroids to reduce airway inflammation.

B) Provide supplemental oxygen to maintain oxygen saturation above 92%.

C) Encourage the patient to perform pursed-lip breathing exercises to improve ventilation.

D) Prepare the patient for a chest X-ray to assess for potential complications.

A patient with asthma exacerbation is receiving supplemental oxygen and systemic corticosteroids. Despite these interventions, the patient exhibits a respiratory rate of 26 breaths per minute, use of accessory muscles, and wheezing. Arterial blood gas analysis shows partially compensated respiratory acidosis. Which nursing intervention should be prioritized to improve the patient's respiratory status?

B) Initiate non-invasive positive pressure ventilation (NPPV).

A) Increase the flow rate of supplemental oxygen.

B) Initiate non-invasive positive pressure ventilation (NPPV).

C) Administer an additional dose of Albuterol inhaler.

D) Encourage the patient to perform incentive spirometry exercises.

A patient with asthma exacerbation is on low-flow oxygen and systemic corticosteroids but remains in respiratory distress with a partially compensated respiratory acidosis. What is the most appropriate next step in management to support her respiratory status?

B) Initiate non-invasive positive pressure ventilation (NPPV)

A) Increase the dose of systemic corticosteroids

B) Initiate non-invasive positive pressure ventilation (NPPV)

C) Administer a higher concentration of oxygen via a non-rebreather mask

D) Schedule more frequent doses of Albuterol inhaler

A patient with a history of asthma is experiencing worsening respiratory distress with arterial blood gas analysis showing a pH of 7.28, PaCO2 of 54 mmHg, and HCO3- of 30 mEq/L. Which of the following nursing interventions is the most appropriate to prioritize at this time?

A) Increase the flow rate of supplemental oxygen to improve oxygen saturation

C) Administer a bronchodilator nebulizer treatment immediately to relieve bronchospasm

D) Position the patient in a high Fowler's position to facilitate lung expansion

A patient with an asthma exacerbation complicated by a bacterial infection is experiencing worsening respiratory acidosis despite low-flow oxygen therapy. The patient is now on non-invasive positive pressure ventilation (NPPV). Which of the following is the priority nursing action to evaluate the effectiveness of the NPPV intervention?

C) Evaluate the patient's arterial blood gas results

A) Assess the patient's heart rate and blood pressure

B) Monitor the patient's oxygen saturation continuously

C) Evaluate the patient's arterial blood gas results

D) Check the patient's level of consciousness and responsiveness

The patient with respiratory acidosis is on non-invasive positive pressure ventilation (NPPV) and showing signs of improvement. However, she reports mild confusion and significant fatigue. What is the priority nursing intervention?

C) Assess the patient’s arterial blood gas results and mental status frequently.

A) Increase the flow rate of NPPV to further assist ventilation.

B) Administer a sedative to help the patient rest and reduce fatigue.

C) Assess the patient’s arterial blood gas results and mental status frequently.

D) Discontinue NPPV and switch to supplemental oxygen via nasal cannula.

A patient with a respiratory infection is being treated with non-invasive positive pressure ventilation (NPPV) and antibiotics. She presents with a pH of 7.32, PaCO2 of 48 mmHg, and HCO3- of 28 mEq/L. Despite initial improvements, she remains fatigued and slightly confused. Which nursing intervention should be prioritized to address her current condition?

C) Assess for signs of CO2 retention and adjust NPPV settings if necessary.

A) Increase the pressure support on the NPPV to enhance ventilation.

B) Initiate deep breathing exercises to improve lung expansion.

C) Assess for signs of CO2 retention and adjust NPPV settings if necessary.

D) Administer a sedative to reduce her anxiety and confusion.

A patient with worsening respiratory acidosis is being treated with Non-Invasive Positive Pressure Ventilation (NPPV). Which nursing intervention is most appropriate to address the patient's current condition?

D) Initiate frequent neurological assessments to monitor changes in mental status.

A) Increase the oxygen flow rate to improve oxygenation.

B) Reposition the patient to a semi-Fowler's position to enhance lung expansion.

C) Encourage deep breathing exercises to reduce CO2 levels.

D) Initiate frequent neurological assessments to monitor changes in mental status.

A patient with worsening respiratory acidosis is being monitored in the ICU. The latest ABG shows a pH of 7.28, PaCO2 of 52 mmHg, and HCO3- of 29 mEq/L. Considering these results and the patient's symptoms of confusion and disorientation, which nursing intervention is most appropriate to address the patient's condition?

A) Increase the rate of the NPPV to improve CO2 elimination

B) Administer a high-flow oxygen therapy to increase oxygen saturation

C) Encourage the patient to perform deep breathing exercises to alleviate CO2 retention

D) Arrange for an immediate intubation to ensure airway protection and adequate ventilation

Asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Inflammation of the airways leads to swelling and increased mucus production, primarily driven by immune cells like eosinophils and T-helper 2 lymphocytes, causing narrowing of the air passages and difficulty in breathing.

• Secondary mechanism: Bronchoconstriction occurs as airway smooth muscles constrict in response to various triggers (e.g., allergens, exercise), further reducing airflow and exacerbating respiratory symptoms.

• Key complication: Chronic airway remodeling can develop due to persistent inflammation, resulting in irreversible changes to airway structure, reduced lung function, and increased frequency of asthma exacerbations.

Patient Profile

Demographics:

42-year-old female, school teacher

History:

• Key past medical history: Diagnosed with asthma at age 15, history of seasonal allergies

• Current medications: Albuterol inhaler as needed, Fluticasone inhaler daily, Montelukast 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing over the past week

• Key symptoms: Persistent cough, chest tightness, waking up at night due to breathlessness, increased use of rescue inhaler

• Vital signs: Blood pressure 140/90 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, oxygen saturation 92% on room air, temperature 98.6°F

Section 1

Change in Patient Status:

Over the following 48 hours, the patient's condition begins to show signs of deterioration despite adherence to her prescribed medication regimen. Notably, her shortness of breath has intensified, and she reports experiencing increased fatigue and difficulty performing daily activities, such as teaching and climbing stairs. The patient notes a persistent, tight feeling in her chest that is not relieved by her Albuterol inhaler, which she is now using more frequently than before. During a follow-up examination, her respiratory rate has increased to 28 breaths per minute, and her oxygen saturation has dropped to 88% on room air. Auscultation reveals diffuse wheezing throughout both lung fields, with diminished breath sounds at the bases.

This change in status prompts a reevaluation of her condition, suggesting that the patient may be experiencing an acute exacerbation of asthma with possible underlying complications such as a developing respiratory infection or more severe inflammatory response. Given her increased respiratory distress and decreased response to bronchodilators, the healthcare team considers further diagnostic testing, including a chest X-ray and arterial blood gas analysis, to assess for potential infection, pneumothorax, or worsening airway obstruction. The importance of timely intervention is underscored, as prolonged hypoxia and increased work of breathing could lead to further complications, such as respiratory fatigue or failure.

The clinical team decides to initiate supplemental oxygen therapy to maintain oxygen saturation levels above 92% and considers the introduction of systemic corticosteroids to reduce airway inflammation. Additionally, a more aggressive approach to managing her asthma action plan is discussed, including potential adjustments to her long-term controller medications. These steps are crucial in stabilizing her condition and preventing further decline, while also addressing any underlying issues contributing to this acute exacerbation. As the patient’s journey continues, careful monitoring and prompt adjustments to her treatment plan are essential to improve her respiratory function and overall well-being.

Section 2

Response to Interventions:

Despite the initiation of supplemental oxygen therapy and the administration of systemic corticosteroids, the patient's condition remains guarded over the next 24 hours. Her oxygen saturation improves slightly to 91% with continuous low-flow oxygen, but her shortness of breath persists, and she continues to rely heavily on her Albuterol inhaler for temporary relief. The clinical team observes that her respiratory rate remains elevated at 26 breaths per minute, and her use of accessory muscles is evident, indicating increased work of breathing. Auscultation still reveals diffuse wheezing, particularly in the upper lung fields, although there is a slight improvement in breath sounds at the bases.

The arterial blood gas analysis provides crucial insights, revealing a partially compensated respiratory acidosis with a pH of 7.32, PaCO2 of 50 mmHg, and HCO3- of 28 mEq/L, suggestive of her body's attempt to counteract the rising carbon dioxide levels due to hypoventilation. The chest X-ray rules out pneumothorax but shows signs of hyperinflation and possible infiltrates, raising concerns about a superimposed infection. The clinical team decides to initiate empirical antibiotic therapy while awaiting sputum culture results, considering the risk of bacterial infection exacerbating her asthma symptoms.

This phase highlights the importance of ongoing evaluation and adjustment of the treatment plan. The team discusses the potential need for non-invasive positive pressure ventilation (NPPV) to support her breathing and alleviate respiratory muscle fatigue if her condition does not improve. Close monitoring of her response to the new interventions, along with regular assessment of her vital signs and lab values, remains critical. The focus is on stabilizing her respiratory status while addressing any underlying complications, paving the way for a gradual recovery and a return to her baseline level of functioning.

Section 3

As the clinical team continues to monitor the patient, a change in her status becomes apparent. Over the next 12 hours, her oxygen saturation begins to fluctuate between 88% and 90% despite the ongoing use of low-flow oxygen. Her respiratory rate has increased further to 30 breaths per minute, and her accessory muscle use is more pronounced, signaling worsening respiratory distress. The patient also reports increased fatigue and a new onset of a productive cough with greenish sputum, which raises further suspicion of a bacterial infection complicating her asthma exacerbation.

The latest arterial blood gas analysis shows a pH of 7.28, PaCO2 of 54 mmHg, and HCO3- of 30 mEq/L, indicating worsening respiratory acidosis. These results suggest that her respiratory muscles are becoming fatigued, and her ability to effectively ventilate is declining. Given these findings, the clinical team decides to implement non-invasive positive pressure ventilation (NPPV) to support her breathing and prevent further deterioration. Meanwhile, the empirical antibiotic therapy is adjusted based on preliminary sputum culture results, which indicate the presence of a bacterial pathogen responsive to a different antibiotic.

The patient’s vital signs are closely monitored, with particular attention to her respiratory rate, heart rate, and blood pressure, as well as her mental status, given the risk of CO2 retention affecting her level of consciousness. The team emphasizes the need for frequent reassessment to evaluate the effectiveness of NPPV and the revised antibiotic regimen. The focus remains on stabilizing her respiratory function and preventing further complications, with the ultimate goal of transitioning her back to spontaneous breathing as her condition improves and the infection is brought under control.

Section 4

Response to Interventions:

Over the next several hours, the clinical team closely monitors the patient's response to non-invasive positive pressure ventilation (NPPV) and the new antibiotic regimen. Initial observations suggest a modest improvement in her respiratory effort, with a slight decrease in accessory muscle use and a reduction in her respiratory rate to 24 breaths per minute. Her oxygen saturation stabilizes at around 92% on NPPV, indicating improved oxygenation. However, her heart rate remains elevated at 110 beats per minute, and her blood pressure shows mild fluctuations, ranging from 140/90 mmHg to 148/94 mmHg, suggesting ongoing stress on her cardiovascular system.

Repeat arterial blood gas analysis reveals a pH of 7.32, PaCO2 of 48 mmHg, and HCO3- of 28 mEq/L, indicating partial resolution of her respiratory acidosis. These changes suggest that while the NPPV is assisting with ventilation and gas exchange, her respiratory muscles are still under significant strain. The sputum culture confirms a bacterial pathogen sensitive to the adjusted antibiotic, and the patient reports a slight decrease in the volume and purulence of her sputum, indicating that the infection is beginning to respond to treatment.

Despite these improvements, the patient continues to experience significant fatigue and reports mild confusion at times, raising concerns about potential CO2 retention effects on her mental status. The clinical team decides to continue NPPV while cautiously optimizing her antibiotic therapy and providing supportive care, including hydration and nutritional support, to enhance her recovery. The focus remains on closely monitoring her mental status and transitioning her to spontaneous breathing as her respiratory function stabilizes further. The team remains vigilant for any signs of new complications, such as potential cardiovascular strain or the risk of barotrauma, as they manage her treatment plan.

Section 5

As the clinical team continues to monitor the patient, they observe a change in her status that raises concern. Over the next several hours, the patient's heart rate increases further to 120 beats per minute, and her blood pressure fluctuates more significantly, with readings ranging from 150/95 mmHg to 158/98 mmHg. These changes indicate that her cardiovascular system is under increasing stress, potentially exacerbating her respiratory challenges. The patient also begins to exhibit more pronounced signs of confusion and disorientation, occasionally struggling to respond appropriately to questions and showing difficulty concentrating. This change in mental status suggests worsening CO2 retention or potentially new central nervous system involvement that warrants further investigation.

To understand the underlying cause of these developments, the team orders a comprehensive metabolic panel and a repeat arterial blood gas analysis. The new ABG results reveal a pH of 7.28, PaCO2 of 52 mmHg, and HCO3- of 29 mEq/L, indicating a worsening of her respiratory acidosis. The metabolic panel shows normal electrolyte levels but indicates a mild increase in lactate to 2.5 mmol/L, suggesting tissue hypoxia. These results point to inadequate ventilation and potential respiratory muscle fatigue, despite the ongoing use of NPPV. The team also conducts a chest X-ray to rule out any underlying pneumonia or atelectasis that may contribute to her deteriorating respiratory status.

In response to these findings, the clinical team decides to enhance the intensity of respiratory support while reassessing the NPPV settings to ensure optimal ventilation. They initiate a more rigorous monitoring protocol, including frequent neurological assessments to closely observe any further changes in her mental status. This escalation in care is aimed at preventing further complications and stabilizing her condition, with the team remaining vigilant for any signs of impending respiratory failure or cardiovascular compromise. The plan includes maintaining a delicate balance between adequate ventilation and minimizing the risk of barotrauma, while continuing to support her recovery from the underlying infection.